entertainment -WSS

entertainment

author：entertainment 2025-10-01 20:15:58 - browse：67994

JOSEPH PREZIOSO/AFP via Getty Images

Late-stage trial results for a pain medication developed by Vertex Pharmaceuticals reinforced experts’ sense that the drug was both safe and offered modest pain relief. But the findings also prompted fresh debate on Tuesday about how widely used the therapy would be should it win regulatory approval.

The company reported that its small molecule drug, VX-548, outperformed placebo in a pair of pain relief trials that recruited patients who had gotten an abdominoplasty (tummy tuck) or bunion surgery. The study also found that the drug was generally safe, with fewer patients on the medication reporting adverse events than those who had taken a placebo. But there was a catch: VX-548 didn’t outperform a combination of acetaminophen and the opioid hydrocodone, a key secondary endpoint. And in the bunionectomy study, the opioid comparator beat VX-548 on pain relief.

“While this study was not explicitly designed to test VX-548 vs. the opioid comparator, this may complicate the prescribing decision in the acute setting, where patients often take a short course of treatment and efficacy is a primary consideration,” Stifel market analyst Paul Matteis wrote in a note to investors, adding that results from three Phase 3 studies were positive overall.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Raw milk easy to obtain despite bird flu warning, FDA interstate ban

hotspot

Wikipedia

WSS

WuXi Biologics beefs up its lobbying operation

HHS suspends federal funding for EcoHealth Alliance

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Elon Musk announces 'temporary limits' for reading Twitter posts

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Greece's new parliament sworn in following conservative party's election victory

hotspot

entertainment

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

FDA approval of Sarepta Duchenne genetic therapy gives me hope

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

Dobbs anniversary: the lost opportunity of abortion as health care

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Walensky prepares to leave CDC — and Congress — behind

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Anesthesiologist group: stop taking Ozempic before surgery

Elon Musk announces 'temporary limits' for reading Twitter posts

leisure time

4 dead, 2 in stable condition in Philadelphia shooting: Police

As H5N1 spreads in cows, experts warn against drinking raw milk

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Supreme Court to hear if Covid misinformation is protected speech

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

A timeline of the missing Titanic tourist submersible

leisure time

hotspot

Wikipedia

explore